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ed  in  7  patients;  5  were  co-infected 
with HBoV (2 patients had LRTIs, 2 
had upper respiratory tract infections, 
and 1 had undefined symptoms), and 
2  were  co-infected  with  RSV  (both 
patients had symptoms of LRTIs). Of 
the other 3 patients co-infected with 
HRV and HBoV, 1 was infected with 
HRV-B  (had  LRTI),  1  with  HRV-C 
(had LRTI), and 1 with an untypeable 
HRV (had undefined symptoms). Co-
infections  with  HRV  and  RSV  (4,5) 
and  HRV  and  HBoV  (4)  have  been 
reported.
Although the clinical role of these 
co-infections  needs  to  be  clarified, 
these  studies  suggest  that  co-infec-
tions may result in more severe dis-
ease symptoms. The role of HRV-C in 
causing illness among the children of 
Singapore will require further study.
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Nondominant  
Hemisphere  
Encephalitis in  
Patient with Signs 
of Viral Meningitis, 
New York, USA 
To the Editor: Herpes simplex 
virus  (HSV)  is  the  most  common 
cause  of  sporadic  fatal  encephalitis 
across the globe and for all ages. HSV 
is the etiologic agent of 10%–20% of 
the 20,000 cases of encephalitis per 
year in the United States (1); >50% 
of  untreated  cases  are  fatal.  Of  the 
2 types of HSV, HSV-1 and HSV-2, 
HSV-1 most commonly affects per-
sons  20–40  years  of  age,  whereas 
HSV-2  commonly  affects  neonates. 
This rapidly progressive disease is a 
common  cause  of  fatal  encephalitis 
in the United States. Signs and symp-
toms include fever and headache for 
a few days, followed by confusion, 
focal deficits, seizures or hemipare-
sis, hallucinations, and altered levels 
of consciousness (2). One third of all 
HSV  encephalitis  cases  afflict  chil-
dren and adolescents. Lumbar punc-
ture  typically  shows  lymphocytic 
pleocytosis,  increased  erythrocytes, 
and  elevated  protein  (2);  glucose 
level is typically within normal lim-
its. Serologic assays often show prior 
infection.  Brain  imaging  frequently 
indicates unilateral frontal or tempo-
ral lobe abnormalities with edema or 
hematoma (3,4). The involvement of 
the  nondominant  brain  hemisphere 
is associated with atypical signs and 
symptoms  (5).  Diagnosis  is  usually 
made by using PCR to examine vi-
ral DNA in cerebrospinal fluid (CSF) 
(6). This method of finding DNA in 
CSF  is  highly  sensitive  (98%)  and 
specific (94%–100%). Without thera-
py, 70% of patients die; with therapy, 
20%–30%  die  (6).  Illness  includes   
behavioral sequelae.
A 43-year-old female immigrant 
from China was admitted to Flushing LETTERS
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Hospital Medical Center in Flushing, 
New York, with complaints of head-
ache, fever, and vomiting, which she 
had experienced for ≈1 week. She had 
no  photophobia,  confusion,  or  rash; 
neurologic examination found no ab-
normalities. CSF contained 81 leuko-
cytes with 82% lymphocytes, 3 eryth-
rocytes,  protein  at  194  mg/dL,  and 
glucose at 67 mg/dL. CSF was posi-
tive for HSV-1 viral DNA by PCR. A 
computed  tomography  (CT)  scan  of 
the head showed unilateral temporal 
lobe  edema.  Intravenous  acyclovir 
10 mg/kg every 8 hours was adminis-
tered. HIV test was negative. On day 
5, a repeat CT scan showed worsening 
edema and hemorrhage, despite clini-
cal improvement (Figure). CSF con-
tained 490 leukocytes with 99% lym-
phocytes  and  protein  at  336  mg/dL. 
After  continued  treatment  with  par-
enteral acyclovir, the patient’s symp-
toms resolved. On day 12, the patient 
was discharged after a final CT scan 
showed resolution of hemorrhage and 
edema and CSF contained decreased 
leukocytes and protein.
Although this patient had classic 
signs of meningitis without encepha-
litis, the CT scan of the head showed 
cerebral  involvement.  These  factors 
can  be  explained  by  the  location  of 
cerebral inflammation in the nondom-
inant lobe of the brain, thereby mask-
ing signs of encephalitis. The classic 
teaching that viral meningitis may not 
need  treatment  may  miss  the  occa-
sional viral encephalitis if brain imag-
ing and CSF PCR are not performed. 
Failure to perform these tests may lead 
to illness and death from HSV enceph-
alitits if this disease is not considered 
as a possible diagnosis.
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Tick-Borne  
Rickettsiosis in 
Traveler Returning 
from Honduras
To  the  Editor:  Although  tick-
borne  rickettsioses  are  widespread 
globally, few reports document their 
presence in Central America (1). Sero-
surveys detected rickettsial antibodies 
in humans in Central America in 1971 
in Costa Rica, Honduras, Nicaragua, 
and  Panama  (2,3).  An  outbreak  of 
rickettsial illness was reported to have 
occurred in Costa Rica in 1974, where 
2 case clusters affected 6 of 15 fam-
ily members (4). A rickettsial organ-
ism was isolated from a patient who 
died in Panama in 1950 (5), and more 
recently Rickettsia rickettsii was con-
Figure.	Computed	tomograph	scan	showing	hemorrhage	in	edematous	part	of	brain	of	
patient	with	herpes	simplex	virus	encephalitis,	day	5	of	hospitalization.